LTS Lohmann Therapie-Systeme Overview
- Year Founded
-
1984
- Status
-
Private
- Employees
-
1,500
- Latest Deal Type
-
Grant
- Financing Rounds
-
6
- Investments
-
3
LTS Lohmann Therapie-Systeme General Information
Description
Manufacturer of transdermal systems and oral thin films intended to serve the pharmaceutical industry. The company specializes in developing and manufacturing drug delivery systems by researching complementary micro-array patches for the transdermal delivery of large molecule, biological actives, enabling doctors to offer their patients reliable and safe therapeutic efficacy.
Contact Information
Website
www.ltslohmann.comCorporate Office
- Lohmannstraße 2
- 56626 Andernach
- Germany
Corporate Office
- Lohmannstraße 2
- 56626 Andernach
- Germany
LTS Lohmann Therapie-Systeme Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
LTS Lohmann Therapie-Systeme Comparisons
Industry
Financing
Details
LTS Lohmann Therapie-Systeme Competitors (14)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Corium International | Private Equity-Backed | Boston, MA | ||||
| Prosolus | Venture Capital-Backed | Miami, FL | ||||
| Nemera | Private Equity-Backed | Lyon, France | ||||
| Medherant | Venture Capital-Backed | Coventry, United Kingdom | ||||
| Lubrizol Particle Sciences | Corporate Backed or Acquired | Bethlehem, PA |
LTS Lohmann Therapie-Systeme Patents
LTS Lohmann Therapie-Systeme Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| DE-102023101977-A1 | Application device for microneedles, system for microneedle application and method for providing a system for microneedle application | Pending | 27-Jan-2023 | ||
| DE-102022132085-A1 | 3d in vitro permeation model | Active | 02-Dec-2022 | ||
| EP-4302751-A1 | Oral thin films with low water activity | Inactive | 07-Jul-2022 | ||
| EP-4302750-A1 | Oral thin films comprising adrenaline | Inactive | 07-Jul-2022 | ||
| DE-102022115044-A1 | Dialysis patch | Pending | 15-Jun-2022 | A61F13/00063 |
LTS Lohmann Therapie-Systeme Executive Team (8)
| Name | Title | Board Seat |
|---|---|---|
| Sebastiaan Van Buijtenen | Chief Executive Officer & Chairman of the Executive Board | |
| Ulrich Sielaff | Chief Financial Officer & Board Member | |
| Claudia Schaefer | Chief Operating Officer & Board Member |
LTS Lohmann Therapie-Systeme Board Members (11)
| Name | Representing | Role | Since |
|---|---|---|---|
| LTS Lohmann Therapie-Systeme | Chief Operating Officer & Board Member | ||
| Self | Supervisory Board Member | ||
| LTS Lohmann Therapie-Systeme | Chief Executive Officer & Chairman of the Executive Board | ||
| LTS Lohmann Therapie-Systeme | Chief Financial Officer & Board Member |
LTS Lohmann Therapie-Systeme Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
LTS Lohmann Therapie-Systeme Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
LTS Lohmann Therapie-Systeme Investments & Acquisitions (3)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Sorrel Medical | 08-Jun-2023 | Other Devices and Supplies | |||
| Micron Biomedical | 25-Nov-2022 | Drug Discovery | |||
| Tapemark | 19-Aug-2022 | Buyout/LBO | BPO/Outsource Services |
LTS Lohmann Therapie-Systeme FAQs
-
When was LTS Lohmann Therapie-Systeme founded?
LTS Lohmann Therapie-Systeme was founded in 1984.
-
Who is the CEO of LTS Lohmann Therapie-Systeme?
Sebastiaan Van Buijtenen is the CEO of LTS Lohmann Therapie-Systeme.
-
Where is LTS Lohmann Therapie-Systeme headquartered?
LTS Lohmann Therapie-Systeme is headquartered in Andernach, Germany.
-
What is the size of LTS Lohmann Therapie-Systeme?
LTS Lohmann Therapie-Systeme has 1,500 total employees.
-
What industry is LTS Lohmann Therapie-Systeme in?
LTS Lohmann Therapie-Systeme’s primary industry is Drug Delivery.
-
Is LTS Lohmann Therapie-Systeme a private or public company?
LTS Lohmann Therapie-Systeme is a Private company.
-
What is LTS Lohmann Therapie-Systeme’s current revenue?
The current revenue for LTS Lohmann Therapie-Systeme is .
-
Who are LTS Lohmann Therapie-Systeme’s investors?
Bill & Melinda Gates Foundation and dievini have invested in LTS Lohmann Therapie-Systeme.
-
Who are LTS Lohmann Therapie-Systeme’s competitors?
Corium International, Prosolus, Nemera, Medherant, and Lubrizol Particle Sciences are some of the 14 competitors of LTS Lohmann Therapie-Systeme.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
